NCT04289467View on ClinicalTrials.gov

Treatment of Refractory Infantile Spasms With Fenfluramine

PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 16, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Infantile Spasm
Interventions
DRUG

Fenfluramine

Open-label

Trial Locations (2)

90095

NOT_YET_RECRUITING

UCLA Health, Los Angeles

92868

RECRUITING

Children's Hospital of Orange County, Orange

All Listed Sponsors
lead

Children's Hospital of Orange County

OTHER

NCT04289467 - Treatment of Refractory Infantile Spasms With Fenfluramine | Biotech Hunter | Biotech Hunter